Back
Veru Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
34
VERU
Veru
Last Price:
1.31
Seasonality Move:
1.56%
Sell
50
EYPT
EyePoint Pharmaceuticals
Last Price:
11.83
Seasonality Move:
6.87%
Sell
34
Veru (VERU)
is a Sell
Is Veru a Buy, Sell or Hold?
- The current Veru [VERU] share price is $1.32. The Score for VERU is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- VERU is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $11.84. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VERU Stock Price Chart
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $11.84
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
VERU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 49.73 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.25 - 1.53) | Sell |
| Bollinger Bands (100): | (0.41 - 1.21) | Buy |
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.16 | Sell |
| Relative Strength Index (14 RSI): | 33.49 | Sell |
| Chaikin Money Flow: | -950333 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.51 - 19.29) | Sell |
| Bollinger Bands (100): | (17.37 - 26.89) | Sell |
VERU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.38 | Sell |
| 20-day SMA: | 1.4 | Sell |
| 50-day SMA: | 1.1 | Buy |
| 200-day SMA: | 0.88 | Buy |
| 8-day EMA: | 1.4 | Sell |
| 20-day EMA: | 1.37 | Sell |
| 50-day EMA: | 1.17 | Buy |
| 200-day EMA: | 1.29 | Buy |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.29 | Sell |
| 20-day SMA: | 14.91 | Sell |
| 50-day SMA: | 18.8 | Sell |
| 200-day SMA: | 16.41 | Sell |
| 8-day EMA: | 12.77 | Sell |
| 20-day EMA: | 14.74 | Sell |
| 50-day EMA: | 17.9 | Sell |
| 200-day EMA: | 16.83 | Sell |
Veru Earnings Growth & VERU Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and a decrease next year of $0.06 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.85 per share.
Veru Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EyePoint Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||